Promising diagnostic model for systemic lupus erythematosus using proteomic fingerprint technology

Journal of Sichuan University (Medical Science)

Volumn 40, Issue 3, 2009, Pages 499-503

  Huang, Zhuo Chun ^a   Shi, Yun Ying ^a   Cai, Bei ^a   Wang, Lan Lan ^a   Wu, Yong Kang ^a   Ying, Bin Wu ^a   Feng, Wei Hua ^a   Hu, Chao Jun ^a   Li, Yong Zhe ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Proteomic fingerprint technology; Systemic lupus erythematosus

Indexed keywords

EID: 67649992245     PISSN: 1672173X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Thomas L. Clinical laboratory diagnostics-use and assessment of clinical laboratory results. 1st ed. Germany: TH-Books Verlagsgesellschaft mbH, Frankfurt/Main, 1998:793-796.
2. Posadas EM, Simpkins F. Liotta LA, et al. Proteomic analysis for the early detection and rational treatment of cancer-realistic hope? Annals of Oncology, 2005;16 (1) :16-22.
3. Marshall J. Kupchak P. Zhu W. et al. Processing of serum proteins underlies the mass spectral fingerprinting of myocardial infarction. J Proteome Res, 2003;2 (4) :361-372.
4. Bauer JW, Baechler EC, Petri M. et al. Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus. PLoS Medicine/Public Library of Science, 2006;3 (12) :e491.
5. Suzuki M. Ross GF, Wiers K. et al. Identification of a urinary proteomic signature for lupus nephritis in children. Pediatric Nephrology, 2007;22 (12) :2047-2057.
6. Mosley K. Tam FW, Edwards RJ, et al. Urinary proteomic profiles distinguish between active and inactive lupus nephritis. Rheumatology, 2006; 45 (12) : 1497-1504.
7. Rovin BH, Birmingham DJ, Nagaraja HN, et al. Biomarker discovery in human SLE nephritis. Bulletin of the NYU Hospital for Joint Diseases, 2007;65 (3) :187-193.